MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation ROCE Ratio 2011-2026 | EW
Annual ROCE Ratio Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.23 | 13.79 | 19.48 | 25.8 | 28.96 | 19.62 | 22.18 | 24.12 | 23.82 | 19.71 | 17.94 | 15.62 | 19.1 | 21.79 | 18.24 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 28.96 | 12.23 | 20.16 |
Quarterly ROCE Ratio Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.45 | 15.09 | 16.08 | 13.39 | 18.83 | 20.62 | 19.82 | 15.93 | 22.41 | 23.44 | 27.08 | 21.71 | 28.75 | 29.33 | 32.15 | 25.84 | 33.66 | 34.44 | 20.17 | 11.94 | 19.04 | 18.31 | 28.47 | 20.15 | 28.08 | 28.91 | 30.49 | 23.99 | 31.23 | 30.55 | 30.67 | 25.48 | 25.48 | 18.24 | 10.09 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 34.44 | 10.09 | 23.27 |
ROCE Ratio of other stocks in the Medical devices industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
978.11 | - | 37.08 % | $ 85.7 M |  USA |
 |
Abbott Laboratories
ABT
|
15.45 | $ 104.93 | 0.34 % | $ 183 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-6.16 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-11.39 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-89.32 | - | 24.59 % | $ 44.8 M |  China |
 |
Dynatronics Corporation
DYNT
|
-75.2 | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
-97.25 | - | 1.37 % | $ 20.5 M | USA |
 |
Align Technology
ALGN
|
15.77 | $ 167.25 | -5.68 % | $ 12.5 B | USA |
 |
Acutus Medical
AFIB
|
1334.24 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-24.19 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-191.02 | - | -5.86 % | $ 30.6 M | USA |
 |
Accuray Incorporated
ARAY
|
9.66 | $ 0.4 | 6.74 % | $ 41.1 M | USA |
 |
Alphatec Holdings
ATEC
|
-660.94 | $ 11.08 | -3.82 % | $ 1.66 B | USA |
 |
Conformis
CFMS
|
-85.42 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-14.35 | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
-175.18 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
-96.4 | - | - | $ 475 M | USA |
 |
Bruker Corporation
BRKR
|
14.21 | $ 34.41 | -2.65 % | $ 5.13 K | USA |
 |
Boston Scientific Corporation
BSX
|
14.91 | $ 69.2 | -1.38 % | $ 102 B | USA |
 |
Avinger
AVGR
|
268.22 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
0.33 | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
-86.24 | $ 9.17 | -2.34 % | $ 260 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-804.35 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
9.93 | $ 35.66 | -2.67 % | $ 1.11 B | USA |
 |
Soliton, Inc.
SOLY
|
-46.49 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-124.26 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-22.41 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
-571.29 | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
-10.4 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-344.26 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
-36.94 | - | - | $ 955 M | USA |
 |
Electromed
ELMD
|
22.36 | $ 24.33 | -0.51 % | $ 206 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-151.13 | $ 0.59 | -1.62 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
-182.32 | $ 2.21 | -2.64 % | $ 3.45 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-165.66 | $ 56.38 | -5.9 % | $ 1.67 B |  Costa-rica |
 |
PAVmed
PAVM
|
127.8 | $ 8.75 | -2.13 % | $ 63.3 M | USA |
 |
BIOLASE
BIOL
|
7261.94 | - | -13.19 % | $ 166 K | USA |
 |
FONAR Corporation
FONR
|
2.84 | $ 18.54 | -0.03 % | $ 122 M | USA |
 |
InspireMD
NSPR
|
-84.53 | $ 1.65 | -4.75 % | $ 106 M | Israel |
 |
Helius Medical Technologies
HSDT
|
-528.85 | $ 1.92 | -4.48 % | $ 1.17 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.84 | $ 9.36 | -0.21 % | $ 721 M | USA |
 |
Inogen
INGN
|
-15.71 | $ 6.3 | -3.08 % | $ 168 M | USA |
 |
AdaptHealth Corp.
AHCO
|
5.98 | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
IRIDEX Corporation
IRIX
|
-105.09 | $ 0.97 | -28.0 % | $ 15.6 M | USA |
 |
IRadimed Corporation
IRMD
|
27.63 | $ 97.63 | -1.12 % | $ 1.24 B | USA |
 |
Penumbra
PEN
|
13.26 | $ 335.13 | -0.38 % | $ 13 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-8.49 | $ 15.74 | -3.73 % | $ 369 M | USA |
 |
LivaNova PLC
LIVN
|
16.62 | $ 61.48 | -3.41 % | $ 3.35 B |  Britain |
 |
LENSAR
LNSR
|
-219.35 | $ 5.59 | 1.27 % | $ 64.4 M | USA |